A. V. Kulish

A. V. Kulish

Auto-generated profile, based on publicly available information

A. V. Kulish

S.M. Kirov Military Medical Academy, Ministry of Defense of Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2022 in Medical Visualization
Verified
Journal Article
Open access
PDF file
ЕБЕ. А. Бусько
Е. А. Бусько
MSM. A. Shagal
M. A. Shagal
AVA. V. Vasiliev
A. V. Vasiliev
VAV. S. Apollonova
V. S. Apollonova
ATA. I. Tseluiko
A. I. Tseluiko
LSL. N. Shevkunov
L. N. Shevkunov
One of the actual problems of oncology is the early diagnosis of breast cancer. However, there are some difficulties not only in diagnostic but also in the verification of lesions. Image-guided cor-biopsy nowadays became the gold standard for verification of non-palpable breast lesions. The main issue is to choose the method of visualization. According to up-to-date recommendations, there is no universal method with all requirements (high visualization quality, convenience, and accessibility for biopsy). Fusion-biopsy or virtual real-time sonography can combine MRI diagnostic potential and facility of US Aim : to leverage the technique of fusion biopsy under combined ultrasound/MR control for verification of breast lesions identified only on MRI and occult on MG and US. Methods. 30 high-risk patients, who had pathological breast lesions detected by diagnostic CE-MRI, classified as BI-RADS 4, 5 yet occult on the other visualization methods were enrolled in the study. All patients underwent supine MRI prebiopsy examination, real-time virtual sonography of the lesions, image-guided biopsy or excisional biopsy, histopathologic examination. Results. The breast fusion-biopsy method was developed based on up-to-date scientific publications and optimized for the technical equipment of N.N. Petrov National Medicine Research Center of Oncology. According to the designed protocol of examination, there were the following steps: interpretation of breast CE-MRI in the standard prone position for breast lesion detection, prebiopsy CE-MRI performed in the supine position, real-time virtual sonography for comparison of breast MRI and US, histopathologic examination. Conclusion. Being one of the perspectives methodic of morphological verification Fusion-biopsy might become a more common procedure in breast lesions diagnostics. The simplicity of US-guided biopsy and high MRI breast diagnostic sensitivity are combined in fusion-biopsy technology.

9 May 2025 in Cancer Urology
Verified
Journal Article
Open access
PDF file
RNR. V. Novikov
R. V. Novikov
VKV. K. Karandashov
V. K. Karandashov
TZT. V. Zhivulina
T. V. Zhivulina
OPO. I. Ponomareva
O. I. Ponomareva
IBI. A. Burovik
I. A. Burovik
SNS. N. Novikov
S. N. Novikov
Aim. To evaluate the immediate results of perineal implantation of a biodegradable spacer based on stabilized hyaluronic acid (SНA) of non-animal origin as a way to optimize radiation treatment of prostate cancer.Materials and methods. The study included 48 patients with verified low and intermediate risk prostate cancer per NCCN (National Comprehensive Cancer Network) who received five-fraction stereotactic radiotherapy as radical treatment. Prior to radiotherapy, all patients underwent insertion of a prostate-rectum biodegradable spacer (PRBS) based on synthetic SHA in the volume of 4–8 mL.Results. There were no allergic and inflammatory reactions of tissues to the chemical composition of the implanted PRBS. Despite the invasive nature of the procedure, we did not observe any cases of infectious complications.SНA used in the study demonstrated high levels of hydration (swelling) equal to 24.4 ± 1.5 (20.7–27.3) %, as well as temporal and spatial stability, which determined its optimal characteristics for use as a radiotherapeutic spacer. In all 48 patients, the projected distance (≥1 cm) between the prostate gland and the anterior wall of the rectum was achieved before the start of irradiation. The administration of 4 mL of SНA made it possible to achieve optimal symmetry of the formed space only in one (16.7 %) patient. An increase in the implant volume of the polymer to 6 mL increased the number of such cases to 28.6 %, and after injection of 8 mL it increased to 57 %.The use of PRBS made it possible to reduce radiation dose to the rectum from 21.5 % (D0.1cc (dose per 0.1 cm3 of rectum)) (р 0.0001) to 92.8 % (V75 % (volume receiving 75 % or more of the prescribed dose)) (р 0.0001). Dose reduction for one of the most clinically validated parameters – D2cc (dose to 2 cm3 of rectum)) was 31.5 % (р 0.0001) on average.Conclusion. Perineal implantation of a non-animal SНA (Russia) as a radiotherapy spacer in patients with prostate cancer demonstrates excellent safety and efficacy profiles.

5 November 2025 in Voprosy onkologii
Verified
Journal Article
Open access
PDF file
ВКВасилий Кириллович Карандашов
Василий Кириллович Карандашов
РНРоман Владимирович Новиков
Роман Владимирович Новиков
ЕКЕкатерина Сергеевна Круглова
Екатерина Сергеевна Круглова
ОПОльга Игоревна Пономарева
Ольга Игоревна Пономарева
ИБИлья Александрович Буровик
Илья Александрович Буровик
СНСергей Николаевич Новиков
Сергей Николаевич Новиков
Введение. Повышение безопасности лучевого рака предстательной железы (РПЖ) — важнейшая задача современной радиационной онкологии. Разработка методики облучения, позволяющая снизить риски постлучевой эректильной дисфункции, направлена на решение данной задачи. Цель. Оценить механизмы снижения дозы на область сосудистых эректильных критических органов (ЭрКО) при лучевом лечении РПЖ, обусловленные промежностной имплантацией парапростатического биодеградируемого спейсера (ПБС). Материалы и методы. В исследование вошли 20 пациентов с верифицированным РПЖ, которым проводилась стереотаксическая лучевая терапия (СТЛТ) в суммарной очаговой дозе 36,25 Гр. На этапе предлучевой подготовки выполнено промежностное введение отечественного спейсера в объеме 6–8 мл. Для анализа дозиметрических изменений, обусловленных введением биополимера, у каждого пациента рассчитано по четыре (всего 80) плана: стандартный план (СП) до имплантации ПБС без снижения дозы на область сосудистых ЭрКО (СП-1), сосудосберегающий план (ССП) до имплантации ПБС (ССП-1), стандартный план после имплантации ПБС без снижения дозы на область сосудистых ЭрКО (СП-2) и сосудосберегающий план после имплантации ПБС (ССП-2). Результаты. Выявлено фактически полное отсутствие изменений в топографии верхушки предстательной железы относительно базальных структур полового члена. Значимых различий по величине радиационной нагрузки на область сосудистых ЭрКО при стандартном планировании (СП-1 и СП-2) независимо от использования ПБС получено не было. Дополнительная оптимизация, направленная на максимальное снижение дозы в рамках протокола сосудосбережения (ССП-1 и ССП-2), обеспечила существенное снижение дозы на область сосудистых ЭрКО по сравнению со стандартными планами, а имплантация ПБС позволила достигнуть наименьших показателей облучения внутренней половой артерии (р < 0,0001). Выводы. Промежностная имплантация ПБС позволяет повысить эффективность сосудосберегающей лучевой терапии РПЖ за счет временного смещения передней стенки прямой кишки относительно предстательной железы, что улучшает оптимизацию пространственного распределения дозы.

1 December 2024 in Cancer Urology
Verified
Journal Article
Open access
PDF file
RNR. V. Novikov
R. V. Novikov
GLG. A. Lyasovich
G. A. Lyasovich
OPO. I. Ponomareva
O. I. Ponomareva
VKV. K. Karandashov
V. K. Karandashov
IBI. A. Burovik
I. A. Burovik
SNS. N. Novikov
S. N. Novikov
Aim. To assess the impact of topographic anatomy of the critical structures of the penile vessels on the implementation of vessel-sparing radiation therapy for prostate cancer.Materials and methods. The study included 70 patients with verified prostate cancer. All patients underwent topometric computed tomography and magnetic resonance imaging. The target (prostate gland and proximal third of the seminal vesicles), standard critical structures (rectum, bladder, femoral heads), as well as critical vascular structures responsible for erectile function were delineated (bulb of the penis, crura of the corpus cavernosum, internal pudendal artery). The obtained images were subjected to volumetric and spatial analysis using the Eclipse 4.0 (Varian Medical System) planning system.Results. In all 70 patients, adequate visualization of all anatomical structures was achieved. The mean distance between the apex and the penile bulb was 1.35 ± 0.47 (0.35–2.41) cm. In the majority of patients, this index exceeded 1 cm: up to 1 cm – 18 (25.7 %), between 1.1 and 1.5 – 27 (38.6 %), and more than 1.51 cm – 25 (35.7 %). The apical-cavernous distance on the right and left did not differ significantly: 2.05 ± 0.45 (1.12–3.00) and 2.09 ± 0.44 (1.16–3.02) cm, respectively. The internal pudendal artery in the projection of the irradiated volume (prostate gland and proximal third of seminal vesicles) is located at an average distance of 2.5 cm (apex gland) to 4.3 cm (basal parts of the prostate). Analysis (Spearman’s correlation coefficient) did not reveal a significant relationship between the assessed spatial parameters and prostate volume and body mass index.Conclusion. The topographic relationship between the irradiated volumes and erectile vascular structures makes it possible to implement vessel-sparing radiation therapy protocol in the majority of cases (about 75 %).

14 December 2022 in Journal of oncology: diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
AMA. S. Mamontova
A. S. Mamontova
OSO. A. Smirnova
O. A. Smirnova
PGP. Yu. Grishko
P. Yu. Grishko
ANA. O. Nyuganen
A. O. Nyuganen
AKA. V. Kulish
A. V. Kulish
AMA. V. Mishchenko
A. V. Mishchenko
Мультипараметрическая магнитно-резонансная томография в определении прогностических факторов рака шейки матки IB2-IIB стадий после неоадъювантной химиотерапии

14 April 2025 in Diagnostic radiology and radiotherapy
Verified
Journal Article
Open access
PDF file
PBP. V. Balakhnin
P. V. Balakhnin
AKA. G. Karakhanova
A. G. Karakhanova
AKA. V. Kulish
A. V. Kulish
EPE. A. Pavlovskaya
E. A. Pavlovskaya
PGP. Yu. Grishko
P. Yu. Grishko
ЕБЕ. А. Бусько
Е. А. Бусько
INTRODUCTION: Carbon dioxide (СО2) is a safe contrast agent for patients requiring endovascular and angiography-assisted procedures due to lack of renal toxicity and allergic potential. It is highly important in patients with renal failure and allergies to iodinated contrast agents.OBJECTIVE: To demonstrate a clinical case of percutaneous biopsy guided with the flat-detector computed tomography (FDCT) CO2 arteriohepaticography in the patient with suspected metastatic lesion of the liver, history of cervical squamous cell carcinoma and chronic kidney disease (CKD).MATERIALS AND METHODS: A patient with squamous cell carcinoma of the cervix, due to concomitant kidney pathology (chronic tubulointerstitial nephritis, gouty nephropathy, CKD C4 according to the KDIGO classification) has contraindications for iodinated contrast, hence contrast enhanced computed tomography (CT) and regular FDCT angiography. A native CT study revealed a hypodence 17 mm diameter lesion in SVII of the liver. US and MRI data were ambiguous. The presence of a clear hypervascular rim in the arterial and venous phases of dynamic contrast enhancement could not rule out the metastasis. In order to clarify the nature of the lesion in the liver, multidisciplinary team suggested biopsy under digital subtraction angiography and FDCT arteriohepaticography using CO2 as a contrast agent because of the risk of the haemorrage. For this purpose, using the Seldinger technique, through right femoral artery, by means of an Artis Zee angiographic unit (Siemens, Germany) catheterization and gas subtraction angiography of the common hepatic artery were performed. FDCT-CO2-arteriohepaticography of the common hepatic artery was performed afterwards using the same installation and injecting 30 ml of carbon dioxide at the rate of 3 ml/sec (special «Angiodroid» (Italy) CO2 injector was used) and a scanning delay of 3 sec (in 6sDCT Body mode).RESULTS: Вy means of subtraction CO2-arteriohepaticography and FDCT arteriohepaticography using CO2 in SVII of the liver the solitary hypervascular 15 mm lesion was detected. In order to verify the lesion single-shot US and FDCT-guided biopsy was performed. It was followed by a control FDCT arteriohepaticography using CO2 to exclude bleeding. Histopathology refuted metastasis.CONCLUSION: CO2 is a safe contrast agent in patients with renal failure and allergies to iodinated contrast agents. FDCT CO2 arteriohepaticography is an effective alternative method, that allows safe visualization and bleeding control after interventions in patient with renal failure.